MK-1029

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MK-1029, covering 2018-08-28 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003) [Phase 1]